Aterian, Inc. (NASDAQ:ATER) Short Interest Update

Aterian, Inc. (NASDAQ:ATER) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totaling 465,657 shares, a decline of 76.0% from the April 30th total of 1,939,342 shares. Based on an average trading volume of 923,391 shares, the days-to-cover ratio is presently 0.5 days. Currently, 5.3% of the shares of the company are sold short.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. Susquehanna International Group LLP grew its position in shares of Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after purchasing an additional 30,637 shares in the last quarter. Citadel Advisors LLC grew its position in shares of Aterian by 222.0% during the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after purchasing an additional 22,865 shares in the last quarter. XTX Topco Ltd purchased a new position in shares of Aterian during the 2nd quarter valued at $55,000. Finally, Goldman Sachs Group Inc. grew its position in shares of Aterian by 73.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after purchasing an additional 9,026 shares in the last quarter. 7.02% of the stock is currently owned by hedge funds and other institutional investors.

Aterian Stock Performance

ATER stock traded down $0.05 during midday trading on Friday, reaching $1.10. 167,440 shares of the company’s stock traded hands, compared to its average volume of 676,805. The company has a 50-day moving average price of $0.87 and a two-hundred day moving average price of $0.76. Aterian has a 52 week low of $0.52 and a 52 week high of $1.87. The firm has a market capitalization of $11.90 million, a PE ratio of -0.43 and a beta of 0.66.

Aterian (NASDAQ:ATER) last released its quarterly earnings results on Friday, May 15th. The company reported ($0.39) EPS for the quarter, beating analysts’ consensus estimates of ($0.69) by $0.30. The firm had revenue of $0.02 million during the quarter, compared to analyst estimates of $15.82 million. Aterian had a negative net margin of 39.56% and a negative return on equity of 82.05%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, May 19th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

About Aterian

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.